Podcast interview with Medco CMO Robert Epstein and DNA Direct CEO Ryan Phelan

[audio http://website.guild.im/williams/wp-content/uploads/sites/17/2010/02/dnadirect2023.mp3]
Pharmaceutical Benefit Manager Medco Health recently acquired DNA Direct, which provides genetic testing and support services for genomic medicine. The acquisition represents a broadening of Medco's focus from pharmacogenomics to a fuller range of genetic tests, and helps DNA Direct continue its transition from its roots as a consumer-oriented play toward Medco's model of working with employers and health plans.In this podcast interview Medco Chief Medical Officer Dr. Robert Epstein and DNA Direct CEO Ryan Phelan discuss the rationale for the acquisition and anticipated developments over the next few years.